The treatment protocol of pSS is based on the disease process; when extra glandular damage is present, glucocorticoid or immunosuppressive therapy such as TNF inhibitor, hydroxychloroquine, rituximab, methotrexate and cyclophosphamide is used. The gene discussed is TNF; the disease is peeling skin syndrome.